Assignee
NEWMARKET PHARMACEUTICALS LLC
US·8 granted patents·1 pending application·37 citations·filing 2014–2024
Top patents by PatentIndex Score
9 records- 0195US12496295B2Veterinary pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2024·Granted Dec 16, 2025·3 cites·16 claims
- 0295US10918631B2Pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2020·Granted Feb 16, 2021·4 cites·25 claims
- 0394US12005053B2Veterinary pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2021·Granted Jun 11, 2024·3 cites·19 claims
- 0494US10695332B2Pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2018·Granted Jun 30, 2020·8 cites·17 claims
- 0591US11166945B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2020·Granted Nov 9, 2021·2 cites·21 claims
- 0689US10022361B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2014·Granted Jul 17, 2018·9 cites·9 claims
- 0788US9402835B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2014·Granted Aug 2, 2016·8 cites·4 claims
- 0886US2024091211A1Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0979US11844789B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →